Aclaris Therapeutics Reports Second Quarter 2017 Financial Results

Go back to Aclaris Therapeutics Reports Second Quarter 2017 Financial Results
(NASDAQ: ACRS) Delayed: 4.88 +0.38 (8.44%)
Previous Close $4.50    52 Week High $33.88 
Open $4.55    52 Week Low $14.12 
Day High $4.93    P/E N/A 
Day Low $4.50    EPS $0.00 
Volume 1,084,075